Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Cardiovasc. Med.

Sec. Pediatric Cardiology

Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1657644

The Global Burden of Pediatric Infective Endocarditis (5-14 years): Epidemiological Patterns from 1990 to 2021 and Projected Trajectories

Provisionally accepted
Ying  XiaoYing XiaoTingting  SunTingting SunYuling  HouYuling HouZugen  ChengZugen ChengYin  LiYin Li*Yan  LiYan Li*Yuan  LiaoYuan Liao*
  • Kunming Children's Hospital, Kunming, China

The final, formatted version of the article will be published soon.

Background: Pediatric infective endocarditis (IE) remains a rare but life-threatening condition, with substantial morbidity and mortality among children worldwide. Despite advances in cardiac care and infection control, the global burden, temporal trends, and regional disparities of pediatric IE remain poorly characterized. Methods: We conducted a comprehensive analysis of pediatric IE burden among children aged 5–14 years using the Global Burden of Disease (GBD) 2021 dataset. Annual incidence, mortality, and disability-adjusted life years (DALYs) attributable to IE were estimated across 204 countries and territories from 1990 to 2021. Analyses were stratified by sex, region, and socio-demographic index (SDI). An autoregressive integrated moving average (ARIMA) model was applied to forecast pediatric IE trends through 2035. Results: Globally, the incidence of pediatric IE declined by 27.6% (95% UI, –30.9% to –24.9%) and mortality by 21.4% (95% UI, –35.2% to –0.8%) between 1990 and 2021, with an estimated annual percentage change (EAPC) of –1.37% (95% CI, –1.49% to –1.24%) and –0.64% (95% CI, –0.75% to –0.54%), respectively. DALYs decreased by 19.2% (95% UI, –33.2% to 1.9%). Marked disparities persisted, with high-SDI regions, notably China, achieving the greatest reductions in burden, while sub-Saharan Africa and Eastern Europe exhibited stagnant or increasing rates. The ARIMA model projected a potential stabilization or slight rebound in the global pediatric IE burden by 2035, particularly among girls, although wide confidence intervals highlight the uncertainty of long-term forecasts. Conclusions: While significant progress has been made in reducing the global burden of pediatric IE, major geographic and socio-demographic inequalities persist. Sustained efforts to strengthen early detection, risk stratification, prevention (including rheumatic heart disease control and antibiotic prophylaxis), and equitable access to cardiac care are urgently required—especially in low-and middle-income countries. Enhanced surveillance and data collection will be crucial to monitor trends, evaluate interventions, and achieve further reductions in pediatric IE morbidity and mortality.

Keywords: infective endocarditis (IE), Children, Incidence, Mortality, DALYs - disability-adjusted life years, ARIMA (Auto Regressive Integrated Moving Average)

Received: 07 Jul 2025; Accepted: 03 Oct 2025.

Copyright: © 2025 Xiao, Sun, Hou, Cheng, Li, Li and Liao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Yin Li, 454599290@qq.com
Yan Li, 82823606@qq.com
Yuan Liao, 1430307267@qq.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.